Elevated plasma asymmetric dimethylarginine levels in children with beta-thalassemia major may be an early marker for endothelial dysfunction.
Orhan GurselSerkan TapanErdim SertogluEmre TaşçılarIbrahim EkerTalia IleriZumrut UysalAhmet Emin KurekciPublished in: Hematology (Amsterdam, Netherlands) (2017)
The findings of the current study show us that increased plasma ADMA levels in children with beta-thalassemia major may be an early marker for endothelial dysfunction and may play a role in the development of premature atherosclerosis in beta-thalassemia major patients.